Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
12.4M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
9.81M
-
Shares change
-
+4.78M
-
Total reported value, excl. options
-
$127M
-
Value change
-
+$62.3M
-
Number of buys
-
23
-
Number of sells
-
-8
-
Price
-
$12.93
Significant Holders of Forte Biosciences, Inc. - COMMON STOCK (FBRX) as of Q2 2025
37 filings reported holding FBRX - Forte Biosciences, Inc. - COMMON STOCK as of Q2 2025.
Forte Biosciences, Inc. - COMMON STOCK (FBRX) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.81M shares
of 12.4M outstanding shares and own 78.88% of the company stock.
Largest 10 shareholders include FRED ALGER MANAGEMENT, LLC (1.62M shares), JANUS HENDERSON GROUP PLC (1.39M shares), ORBIMED ADVISORS LLC (1.2M shares), FEDERATED HERMES, INC. (1.07M shares), TYBOURNE CAPITAL MANAGEMENT (HK) LTD (787K shares), BVF INC/IL (588K shares), Cable Car Capital, LP (500K shares), SPHERA FUNDS MANAGEMENT LTD. (495K shares), VANGUARD GROUP INC (487K shares), and Ikarian Capital, LLC (476K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.